So-called "right-to-try" is a cruel sham that holds out the mostly false hope of survival to terminally ill patients and their families. In return, all they have to give up is patient protections and agree to pay to be guinea pigs to test a drug company's product. The product of an ideology that uses the terminally ill as shields to hide the ideological motives behind the law, which are to hobble the FDA, right-to-try is a terrible idea. It's bad for patients, but it just passed the Senate and could well become the law of the land when the House reconvenes in September if it isn't stopped.
I didn’t think I’d be revisiting this topic again so soon, but damned if Alice Dreger didn’t write something that comes pretty close to demanding that I do so. I tried to resist, but unfortunately could not. Basically, I’m getting really, really tired of Dreger. Why do I say that? It’s because I’m having a harder and harder time not thinking that she has antivaccine proclivities. I don’t want to. I really don’t. But, damn, if she doesn’t keep sounding like a blogger on Age of Autism or The Thinking Moms’ Revolution.
Report on Research Compliance Volume 20, no. 10 (October, 2023) The HHS Secretary’s Advisory Committee on Human Research Protections (SACHRP) will have two new members.
Speakers From AbbVie, National Institutes of Health, National Organization for Rare Disorders, NYU Grossman School of Medicine and Verily Share Insights on How Medical Innovation Is.